Skip to content
OpenCapital
Get started

Relay Therapeutics, Inc. RLAY Increase (Decrease) in Prepaid Expense

Increase (Decrease) in Prepaid Expense at other companies

Celcuity logo
CelcuityCELC
——

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K—
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0×0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s increase (decrease) in prepaid expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s increase (decrease) in prepaid expense?
Relay Therapeutics, Inc. (RLAY) reported increase (decrease) in prepaid expense of -$7.36M in Q1 2026.
How has Relay Therapeutics, Inc.'s increase (decrease) in prepaid expense changed year-over-year?
Relay Therapeutics, Inc.'s increase (decrease) in prepaid expense decreased by 287.3% year-over-year, from $3.93M to -$7.36M.